Dr. Mauricio Menacho Márquez, Investigador Independiente,,CONICET, Argentina
Dr. Mauricio Menacho Márquez, an accomplished researcher in Genetics and Molecular Biology, has been honored with the Best Researcher Award 🎉. As an Investigador Independiente at CONICET, Argentina 🇦🇷, Dr. Menacho Márquez has significantly advanced our understanding of genetic mechanisms and molecular processes 🧬. His groundbreaking work has been recognized globally 🌍, earning him numerous accolades 🏆. With a commitment to scientific excellence and innovation, Dr. Menacho Márquez continues to inspire future generations of researchers 👨🔬👩🔬, solidifying his reputation as a leading figure in the field of Genetics and Molecular Biology.
PROFILE 📋
Orcid
CURRENT PROFESSIONAL SITUATION 💼
Dr. Mauricio Menacho Márquez is an esteemed Independent Concept Investigator at CONICET and a Professor at Universidad Nacional de Rosario since 2015. He serves as the Deputy Director of IDICER, International Relations Secretary at the Faculty of Medical Sciences, and Scientific Director at the Centro de Investigación y Producción de Reactivos Biológicos. He also leads the Centro de Investigación del Cáncer de Rosario. His research focuses on cancer, drug repositioning, GTPases, synucleins, and resistance 🧬💊🔬. His dedication to advancing medical science is exemplary, contributing significantly to the field of oncology and drug development 🌟📚🏥.
ACADEMIC TRAINING 🎓
🎓 Dr. Mauricio Menacho Márquez boasts an impressive academic background. He graduated in Biotechnology from Universidad Nacional de Rosario, Argentina, on 02/09/1997. Later, he received his License in Biology, officially homologated by the University of Valencia, Spain, on 10/18/2006. He earned his Doctorate from Universidad Politécnica de Valencia, Spain, on 22/11/2007. 🧬📘 His extensive education has laid a solid foundation for his contributions to the field of biotechnology and biology, demonstrating his dedication and expertise. 🥼🔬📚
PRIOR ACTIVITIES OF CIENTIFIC CHARACTER AND TEACHER ACTUATION 🧑🏫
Dr. Mauricio Menacho Márquez has an extensive research background. He served as a Superior Laboratory Technician at Fundación Helios, Universidad Nacional de Rosario (1998-1999) 🔬. He then held various research fellowships: at the Departamento de Farmacología, Universidad Nacional de Rosario (2001-2002) 🧪, Unidad de Investigación Hospital Universitario de Canarias, Spain (2002-2004) 🏥, and Instituto de Biología Molecular y Celular de Plantas, Univ. Politécnica de Valencia, Spain (2004-2007) 🌱. Dr. Menacho Márquez was a Post-Doctoral Investigator at the Centro de Investigación del Cáncer de Salamanca (2008-2014) 🧬, and later, he was a First Auxiliary in Genetics at the Faculty of Medical Sciences, Universidad Nacional de Rosario (2014-2017) 🧬📚.
HUMAN RECORD TRAINING📜
Dr. Mauricio Menacho Márquez has made significant contributions in directing various academic theses and research projects. In 2024, he supervised Senior Directors Manuel Baldovino and Pablo Martínez 🌟. In 2023, he guided medical students Manuel Baldovino and Lucas Cáceres 👩⚕️👨⚕️. From 2021-2023, he led the Master’s specialization in Bioinformatics of Aylén Ávila, achieving outstanding grades 📚🎓. His mentorship spans numerous doctoral theses, including those of Macarena Mamberto and Nahuel Cesatti Laluce, set to complete by 2025 📖🧬. His direction in biotechnological research, particularly at the Cancer Investigation Center of Salamanca, has been highly commendable, earning “Sobresaliente” ratings consistently 🌐🔬.
SCIENTIFIC AND TECHNOLOGICAL FINANCING 💰
Dr. Mauricio Menacho Márquez Rac1 is a leading researcher in cancer therapeutics. His groundbreaking work includes studying new therapies for resistant tumors (PICT 2022-09-00112) and identifying pharmacological targets for colorectal cancer resistant to 5-FU (PEIC I+D 2021). His research on melanoma and neurodegenerative diseases (PICT 2018-00900) and the role of Vav proteins in cancer (PICT 2019-00801) has been pivotal. As Director of multiple projects, he secured funding for drug repositioning and tumor cell metabolism (National Cancer Institute, $500,000) and developed a biomodule for high-quality lab animals ($2,000,000). 🧬💊🎗️🔬🧪
TECHNOLOGICAL PRODUCTION WITH INTELECTUAL PROPERTY CERTIFICATE 📄
🔬✨ Dr. Mauricio Menacho Márquez, along with Xosé R. Bustelo and Citterio C, has made a groundbreaking contribution to cancer treatment. They invented inhibitors of Vav, a novel approach for preparing medicine to treat metastasis. This significant advancement, patented on 15/07/2012, holds promise in the fight against cancer, potentially saving countless lives. The collaborative efforts of these researchers highlight the importance of innovation and dedication in medical research. 👩🔬👨🔬🧬💊
PUBLICATION TOP NOTES 📑